iRhythm Technologies, Inc.

We’ve announced our Q1 2026 financial results. We delivered a strong start to 2026, with $199.4M in revenue, up 25.7% year over year, along with expanding margins and positive adjusted EBITDA. As we celebrate 20 years of innovation, we remain focused on advancing earlier arrhythmia detection across more care settings—delivering on our vision of better data, better insights, and better health for all. Read the full earnings release and access the webcast replay here: https://lnkd.in/g7pprRQF #IRTC #iRhythm #Q12026 #Earnings #FinancialResults #BusinessPerformance

Epic #XGM 2026 attendees, stop by our booth to learn about our EHR integration with Epic via Aura.

Monitoring approach and duration directly impact what is detected — and what is missed. Real-world data presented at the Heart Rhythm Society’s Annual Meeting (HRS 2026) add to the body of evidence supporting a shift away from short-duration 24–48-hour Holter monitoring toward up to 14 days of continuous, uninterrupted monitoring with Zio® ambulatory ECG devices and service, to reduce missed arrhythmias and provide a more complete assessment of arrhythmia burden, including in AF post-ablation and pregnancy populations.(1,2) Read more here: https://lnkd.in/gtqBJq8S #IRTC #iRhythm #Arrhythmia #DigitalHealth #AI #HRS2026

Welcome Clara to the team! Clara joins us as a Marketing Communications Manager. We’re excited to have you on board as we continue to boldly innovate to create trusted solutions that detect, predict, and prevent disease. #LifeAtiRhythm #TeamiRhythm #ZioByiRhythm

Are you attending Epic #XGM 2026? Head to the iRhythm booth now to learn about our availability on Aura.

Welcome Erika to the team! Erika joins us as a Product Director. We’re excited to have you on board as we continue to boldly innovate to create trusted solutions that detect, predict, and prevent disease. #LifeAtiRhythm #TeamiRhythm #ZioByiRhythm

What did we learn at #HRS2026? Conversations across the week reinforced a few key themes: • Monitoring duration continues to matter • Interpreting arrhythmia burden remains complex • Patient experience is increasingly central Thank you to everyone who connected with us in Chicago. See you next year at #HRS2027 in San Francisco, May 13-16. https://lnkd.in/gimseN_Q #HRS2026 #iRhythm #ZiobyiRhythm #Electrophysiology

700,000+ patients. What did real-world monitoring data reveal about arrhythmia care? CAMELOT and AVALON, two of the largest real-world clinical studies in ambulatory cardiac monitoring (ACMs), found the Zio®️ long-term continuous monitoring service was associated with the highest diagnostic yield and lower all-cause cost of care compared to other monitoring modalities. The evidence is reshaping how we think about diagnosing and caring for patients with arrhythmias. Learn how Zio can elevate your approach to arrhythmia detection: https://lnkd.in/g4EBmnvN

Why place cardiac monitoring at the foundation of your cardiovascular service line strategy? In this new Q&A, Amanda Maples, RN, BSN, MHA, shares hard-won lessons from emergency department and primary care nursing to service line leadership. She offers insights on building patient-centered programs that help guide patients through care while supporting the workflows and priorities of care teams. Read the conversation: https://bit.ly/4sX7KDs #CardiacMonitoring #CardiovascularCare #HealthcareOperations #HealthSystemLeadership #PopulationHealth #ServiceLineStrategy #ValueBasedCare

What makes a cardiac monitoring program effective? Erin Cardell, MSN, CRNP and Amanda Maples, BSN, MHA on workflow and quality improvement. Breakfast will be provided For APs at #HRS2026 https://lnkd.in/gimseN_Q #HRS2026 #APLounge #CardiacMonitoring #QualityImprovement #ZiobyiRhythm